20 July 2020: ReNeuron Group plc (AIM: RENE.L), a UK-based global leader in the development of cell-based therapeutics, is pleased to announce its preliminary results for the year ended 31 March 2020.

Read more…

A recording of the webcast can be accessed via the following link:


The presentation can be accessed by clicking here.